Nitrosamine Impurities Affecting Drug-Drug Interaction Studies – Learn More

COVID-19 Vaccines in Development

COVID-19 Vaccines in Development

COVID-19 is a respiratory illness caused by a novel coronavirus. According to the CDC, symptoms may include fever, coughing and shortness of breath. The virus is highly contagious and can spread between people who are in close contact with one another (within 6 feet) or when an infected person coughs or sneezes spraying respiratory droplets.

While the world is grinding to a halt to slow the spread of the COVID-19 through social-distancing, self-isolation and quarantine efforts. The race to find a COVID-19 vaccine has just began. As of March 18th 2020, there are 298 clinical trials for COVID-19 and 129 drugs in the pipeline which may potentially treat this disease (GlobalData).

As we face this ever-growing pandemic, Celerion is ready to work with our pharma and biotech partners to ensure safety and efficacy of COVID-19 vaccine development. Celerion is a leader in vaccine development with infections disease experience. Our track record spans both preventive and therapeutic vaccines, subunit and conjugates across all phases I-IV in more than 20 countries, 300 study centers and 4500 subjects.

We will get through this, together!!